The Effect of Ginseng Extract on Serum Interleukin-6 Levels in Patients with Community-Acquired Pneumonia
DOI:
https://doi.org/10.24293/ijcpml.v28i3.1839Keywords:
Community acquired pneumonia, Ginseng, IL-6Abstract
Community-Acquired Pneumonia (CAP) is the most common cause of death and illness in the world. Increased IL-6 can be used as an early indicator of infection or inflammation. Ginseng is a popular herbal medicine. The anti-inflammatory effect of Ginseng is mediated by its ability to inhibit Nuclear Factor Kappa Beta (NF-kB), a proinflammatory regulator to initiate the synthesis of cytokines TNF-α, IL-1β, IL-6, and IL-8. Clinical trial research, quasi-experimental design with a pretest-posttest approach was carried out on 26 community pneumonia patients who were hospitalized at Dr. Moewardi Hospital, Surakarta from October 2020 to January 2021 using purposive sampling. The independent variable was Ginseng extract (GinsanaR) at a dose of 2x100 mg and the dependent variable was serum IL-6 levels. Serum IL-6 levels were measured using the Sandwich Enzyme-Linked Immunoabsorbent Assay (ELISA) method. Mean IL-6 levels in the control group on day 0, day 3, and day 14 were 232,89+156,61 pg/mL, 113,46±83.30 pg/mL and 66.18±66.02 pg/mL, respectively (p=<0.001). Mean IL-6 levels in the treatment group on day 0, day 3, and day 14 were 519,55±609,19 pg/mL, 205.41±329.17 pg/mL and 133,59±291,68 pg/mL, respectively (p=<0.001). Delta IL-6 levels in the control group and the treatment group on day 3 compared to day 0, the mean of the IL-6 control group -119,42±111,70 pg/mL, the mean for the IL-6 treatment group -314,14±532,16 pg/mL; On day 14 compared to day 0, the mean of the IL-6 control group was -166,70±135,54 pg/mL, the mean of the IL-6 treatment group was -385,96±547,10 pg/mL; On day 14 compared to day 3, the mean IL-6 control group was -47.28±47.47, the mean IL-6 control group was -71.82±58.16. The post hoc test (Wilcoxon) obtained a p-value < 0.05, suggesting that Ginseng extract has a significant effect on reducing serum IL-6 serum levels in community pneumonia patients.
Downloads
References
Mandell LA, Wunderink R. Pneumonia. In: Jameson J, Fauci AS, Kasper DL, Hauser SL, Longo DL, and
Loscalzo J.eds. Harrison's principles of internal medicine. 20th Ed., United States of America,
Mcgraw-Hill Medical Publishing, 2018; 908.
Dahlan Z. Pneumonia buku ajar ilmu penyakit dalam. th 6 Ed., In: W. Sudoyo A, Setiyohadi B, Alwi I, Setiati S, editor, Jakarta, Pusat Penerbitan Departemen Ilmu Penyakit Dalam Fakultas Kedokteran Universitas Indonesia. 2017; 964–71.
Perhimpunan Dokter Paru Indonesia. Pneumonia komunitas. Pedoman diagnosis dan penetalaksanaan di Indonesia. Jakarta, Balai Penerbit FKUI, 2017; 1-5.
Henig O, Kaye KS. Bacterial pneumonia in older adults. Infectious Disease Clinics, 2017; 31(4): 689-713.
Riset Kesehatan Dasar (Riskesdas). Jakarta, Badan Penelitian dan Pengembangan Kesehatan
Kementerian RI, 2018; 73-77.
Tripon RE, Neagoe IB, Budisan L, Pop TL, Cristea V, et al. Systemic interleukins levels in community-acquired pneumonia and their association with adverse outcomes. Revista Romana de Medicina de Laborator, 2019; 27(2): 189-198.
Cilloniz C, Cardozo C, Garcia C. Epidemiology, p a t h o p h y s i o l o g y , a n d m i c r o b i o l o g y o f
community-acquired pneumonia. J Ann Res Hosp, 2018; 1-11.
Jones SA, Fraser DJ, Fielding CA, Jones GW. Interleukin-6 in renal disease and therapy.
Nephrology Dialysis Transplantation, 2015; 30(4): 564-574.
Karak ioulak i M, Stol z D. Biomarker s in pneumonia-beyond procalcitonin. International Journal of Molecular Sciences, 2019; 20(8): 2004.
Shahrajabian MH, Sun W, Cheng Q. A review of Ginseng species in different regions as a multipurpose herb in traditional Chinese medicine, modern herbology, and pharmacological science. Journal of Medicinal Plants Research, 2019; 13(10): 213-226.
Majid Alyaa. Panax ginseng – A review. University of Thi-Qar Journal of Science, 2019; 7 (1): 97-99.
Kim JH, Yi YS, Kim MY, Cho JY. Role of ginsenosides, the main active components of Panax ginseng, in
inflammatory responses and diseases. J Ginseng Res, 2017; 41: 435-43.
Ratan ZA, Haidere MF, Hong YH, Park SH, Lee JO, et al. Pharmacological potential of Ginseng and its major component ginsenosides. Journal of Ginseng Research, 2020; 45(20): 199-210.
Faheem Khan, Mark B Owens, Marcos Restrepo, Povoa P, Martin-Loeches I. Tools for outcome prediction in patients with community-acquired pneumonia. Expert Review of Clinical Pharmacology, 2017; 10(2): 201-211.
Uranga A, España P, Bilbao A, Quintana JM, Arriaga I, et al. Duration of Antibiotic Treatment in
Community-Acquired Pneumonia A Multicenter Randomized Clinical Trial. JAMA Internal Medicine,
; 176(9): 1257–1265.
Melot B, Colot J, Guerrier G. Bacteremic community-acquired infections due to Klebsiella pneumoniae: clinical and microbiological presentation in New Caledonia, 2008–2013. International Journal of Infectious Disease, 2015; 41: 29–31.
Kadhum SA. Antibiotic sensitivity tests of Klebsiella pneumonia isolated from different clinical specimens in Hilla city. Biochem Cell Arch, 2018; 1: 3-7.
Riquelme SA, Ahn D, Prince A. Pseudomonas aeruginosa and Klebsiella pneumonia adaptation to
innate immune clearance mechanisms in the Lung. J Innate Immun, 2018; 10: 442-454.
Bacci MR, Leme RCP, Zing NPC, Murad N, Adami F, et al. IL-6 and TNF-α serum levels are associated with early death in community-acquired pneumonia patients. Brazilian Journal of Medical and Biological
Research, 2015; 48(5): 427-432.
Mendez R, Menendez R, Cilloniz C, Amara, Amaro R, Gonzales P, Posadas T et al. Initial inflammatory profile in community-acquired pneumonia depends on time since onset on symptoms. American Journal of Respiratory and Critical Care Medicine, 2018; 198(3): 393-9.
Waites KB, Li Xiao, Yang Liu, Balish MF, Atkinson TP. Mycoplasma pneumoniae from the respiratory tract and beyond. J Clinical Microbiology Review, 2017; 30(3): 747-809.
Iqbal H, Rhee DK. Ginseng alleviates microbial infections of the respiratory tract: A review. Journal of
Ginseng Research, 2020; 44(2): 194-204.
Downloads
Submitted
Accepted
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
